Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2017 / Article

Corrigendum | Open Access

Volume 2017 |Article ID 3575348 | 1 page | https://doi.org/10.1155/2017/3575348

Corrigendum to “Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model”

Received03 May 2017
Accepted09 May 2017
Published24 Sep 2017

In the article titled “Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model” [1], references [2, 3] should have been included as references 24 and 25 in the original article.

Accordingly, in the introduction section, the text reading “Echocardiographically, MVP is defined as a single or bileaflet prolapse, at least 2 mm beyond the long-axis annular plane, while the assessment of valve regurgitation takes into account the effective regurgitant orifice area (EROA) [2]” should be changed to “Echocardiographically, MVP is defined as a single or bileaflet prolapse, at least 2 mm beyond the long-axis annular plane, while the assessment of the severity of MR relies on several parameters according to the current recommendations [24, 25].”

Additionally, the Acknowledgments section should be updated as follows:

“The authors thank the entire Cardiac Surgery Unit at Centro Cardiologico Monzino for the clinical data and blood collection. The authors also would like to thank Dr. Paola Gripari for patient evaluation and critical review. This work was supported by the Fondazione Gigi e Pupa Ferrari ONLUS and the Italian Ministry of Health [RC2015-BIO30-2613051 to Centro CardiologicoMonzino].”

References

  1. P. Songia, B. Porro, M. Chiesa et al., “Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 6838921, 6 pages, 2017. View at: Publisher Site | Google Scholar
  2. W. A. Zoghbi, D. Adams, R. O. Bonow et al., “Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance,” Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography, vol. 30, no. 4, pp. 303–371, 2017. View at: Publisher Site | Google Scholar
  3. R. A. Nishimura, C. M. Otto, R. O. Bonow et al., “2014 AHA/ACC Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines,” Circulation, vol. 129, no. 23, pp. 2440–2492, 2014. View at: Publisher Site | Google Scholar

Copyright © 2017 Paola Songia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

418 Views | 156 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.